Abstract:Biomimetic nanotechnology through camouflaging synthetic nanoparticles (NPs) with natural cell membranes, which bestows with immune evasion and superior targeting capacity, has been extensively used in drug delivery systems (DDS) over the last decades. These biomimetic NPs not only retain the physicochemical features of the synthetic vehicles but also inherit the cell membranes' intrinsic functionalities. Combined with these benefits, optimized nano-biomimetic DDS allow maximum delivery efficacy. Compared to erythrocyte/cancer single cell membrane, the hybrid cell membrane expressing CD47 membrane protein and self-recognition molecules, from erythrocytes and cancer cells, provides remarkable features to the synthetic vehicles, such as immune evasion, long-term circulation, and homotypic targeting. In this review, we describe the preparation strategies, the camouflaging mechanism, and the antitumor applications of hybrid cell membrane-camouflaged NPs. Moreover, we discuss further modification of the hybrid cell membrane and the surface properties of fusion cellular membranes. Finally, we summarize the primary challenges and opportunities associated with these NPs. STATEMENT OF SIGNIFICANCE: Camouflaging synthetic nanoparticles with hybrid cell membrane has been extensively highlighted in recent years. The resultant biomimetic nanoparticles not only reserve the physicochemical properties of the synthetic nanoparticles but also inherit the biological functions of source cells. Compared with single cell membrane, hybrid cell membrane can endow synthetic nanoparticles with multiple biofunctions derived from the original source cells. To provide a timely review of this rapidly developing subject of research, this paper summarized recent progress on the hybrid cell membrane-camouflaged nanoparticles as drug delivery systems for cancer diagnosis and treatment. In this review, we focused primarily on five different types of hybrid cell membrane-camouflaged nanoparticles with the preparation strategies, the camouflaging mechanism, and the antitumor applications. Moreover, further modification of the hybrid cell membrane was also discussed for isolating effectively circulating tumor cells.

Self-Assembled Hybrid Nanostructures: Versatile Multifunctional Nanoplatforms for Cancer Diagnosis and Therapy

Self-Assembled Organic Nanomaterials For Drug Delivery, Bioimaging, And Cancer Therapy

In Situ Self-Assembled Nanomedicines for Cancer Treatment

Self-assembled polymer nanostructures for delivery of anticancer therapeutics

Advances in cancer theranostics using organic-inorganic hybrid nanotechnology

Supramolecular peptide nano-assemblies for cancer diagnosis and therapy: from molecular design to material synthesis and function-specific applications

Self-assembled magnetic nanomaterials: Versatile theranostics nanoplatforms for cancer

Self-Assembled Nanomaterials for Enhanced Phototherapy of Cancer.

How the Versatile Self‐Assembly in Drug Delivery System to Afford Multimodal Cancer Therapy?

In situ self-assembly for cancer therapy and imaging

Hybrid cell membrane-coated nanoparticles: A multifunctional biomimetic platform for cancer diagnosis and therapy

Silicon Nanostructures for Cancer Diagnosis and Therapy

Multistage Self-Assembled Nanomaterials for Cancer Immunotherapy

Hybrid Nanoparticles as Drug Carriers for Controlled Chemotherapy of Cancer

Self-Assembly of Small Organic Molecules into Luminophores for Cancer Theranostic Applications

Self‐Assembled Nanoparticles as Cancer Therapeutic Agents

Cerasomes And Bicelles: Hybrid Bilayered Nanostructures With Silica-Like Surface In Cancer Theranostics

In Situ Self-Assembled Peptide Nanofibers For Cancer Theranostics

Hybrid Nanomaterials for Cancer Immunotherapy

Designed fabrication of mesoporous silica-templated self-assembled theranostic nanomedicines

Application of molecular dynamics simulation in self-assembled cancer nanomedicine